<DOC>
	<DOCNO>NCT00572585</DOCNO>
	<brief_summary>This study evaluate efficacy , safety tolerability AEB071 treatment active , moderate severe ulcerative colitis patient fail conventional therapy use mesalamine steroid</brief_summary>
	<brief_title>Efficacy , Safety Tolerability AEB071 Patients With Active , Moderate Severe Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>1875 year males female Female subject childbearing potential must use two method contraception Active , moderate severe disease Poor response toleration conventional therapy ( e.g . steroid , mesalamine ) Good communication investigator , understand compliance requirement study write informed consent Allergy drug Very low high body weight Ongoing treatment specific medication ( e.g . antibiotic ) Diagnosis primary sclerosing cholangitis Renal impairment Toxic megacolon Presence history specific disease , cancer , cardiac abnormality , abnormal laboratory finding History alcohol drug abuse Pregnant breastfeed woman Positive HIV , Hepatitis B Hepatitis C test result Other protocoldefined inclusion/exclusion criterion apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Ulcerative colitis</keyword>
	<keyword>immunosuppressive therapy</keyword>
	<keyword>AEB071</keyword>
	<keyword>Modified Baron score</keyword>
	<keyword>Partial Mayo score</keyword>
</DOC>